Metoprolol (versus unexposed) updated on 12-17-2024

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)3.71 [1.33, 10.34]-1 study4,05847not evaluable ROB6.88 [2.00; .]
Major congenital malformations3.71 [1.33, 10.34]-1 study4,05847not evaluable ROB6.88 [2.00; .]
2 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Small for gestational age (weight)1.74 [0.96, 3.14]6%3 studies32,530352not evaluable ROB-
Low birth weight (< 2500g)2.57 [2.35, 2.80]0%2 studies19,436870not evaluable ROB4.57 [4.14; .]
Preterm (< 37 weeks)2.07 [1.88, 2.27]-1 study490not evaluable ROB3.56 [3.17; .]
Very low birth weight (< 1500g)3.43 [1.83, 6.45]-1 study3,451324not evaluable ROB6.32 [3.06; .]

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Caesarean2.26 [1.77, 2.89]79%2 studies104,3421,975not evaluable ROB3.95 [2.94; .]
2 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Low Apgar score (< 7) (at 5 min)3.11 [1.54, 6.28]-1 study3,032324not evaluable ROB5.67 [2.45; .]
Low Apgar score (< 7) (NOS)1.59 [1.46, 1.74]-1 study593not evaluable ROB2.56 [2.27; .]
Neonatal hypoglycemia1.64 [1.15, 2.33]-1 study1401,484not evaluable ROB2.66 [1.57; .]
3 non statistically significant endpoints reported in only one study

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons